We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Vaccine Research Summit

Vaccine Research Summit

Vaccine Research Summit

Vaccine Research Summit

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Vaccine Research Summit"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Join the industry professionals in attendance at the Old Royal Naval College - Greenwich, London, UK on the 27th - 28th Sept 2011 for a chance to discuss the latest trends and developments in Vaccine Research.

Appel Consulting’s Vaccine Research conference tackles these issues with a fresh perspective; join our unique summit today.

Network with senior level executives from the top 20 pharmaceutical and biotechnology industries. Our summit will focus on Exploring Innovation in Vaccine Research and development. Hear key addresses from industry leaders  concerning commercial and business development of novel adjuvant vaccines.

Scientific presentations will provide in-depth coverage on topics including accelerating vaccine research, practical considerations for the design and conduct of vaccine clinical trials, challenges of conducting global vaccination studies and vaccine manufacturing with sessions dedicated to using the avian embryonic stem cell line .

Our Vaccine Research & Development Conference will encompass seven scientific areas

1) Future trends in vaccine discovery & new vaccines
2) Human vaccines focusing on infectious diseases, bacterial & viral
3) Advances in technology for the purification and manufacturing of vaccines
4) Adult and adolescent immunization
5) Scientific progress in TB & Malaria
6) The development of therapeutic vaccines
7) The commercial & business development of novel adjuvant vaccines

Hear keynote addresses from:

•Dr Vincent Dupriez, Principal Scientist, PerkinElmer
•Dr Glynis Neagle, Chief Medical Officer, Synexus
•Dr Matthias Hebben, Director R&D Virology, Vivalis
•Dr Jenny Hendriks, Senior Scientist, Crucell
•Dr Lidija Urbas, Senior Research Scientist, BIA Separations